共 50 条
- [34] Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (09): : 761 - 769
- [35] Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2013, 104 (09): : 807 - 814
- [38] Risankizumab Versus Ustekinumab for the Achievement of Endoscopic Outcomes in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 3b SEQUENCE Trial [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I90 - I91
- [39] Molecular response to ustekinumab in moderate-to-severe Crohn's disease by serum protein and biopsy gene expression analysis: results from Ustekinumab phase 3 studies [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S57 - S58